H

Huakang Biomedical Holdings Co Ltd
HKEX:8622

Watchlist Manager
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Watchlist
Price: 0.185 HKD -11.06% Market Closed
Market Cap: 92.6m HKD
Have any thoughts about
Huakang Biomedical Holdings Co Ltd?
Write Note

Intrinsic Value

8622 doesn't have a meaningful market cap.

The intrinsic value of one Huakang Biomedical Holdings Co Ltd stock under the Base Case scenario is 0.089 HKD. Compared to the current market price of 0.185 HKD, Huakang Biomedical Holdings Co Ltd is Overvalued by 52%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
0.089 HKD
Overvaluation 52%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation Backtest
Huakang Biomedical Holdings Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Huakang Biomedical Holdings Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Huakang Biomedical Holdings Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Huakang Biomedical Holdings Co Ltd

Provide an overview of the primary business activities
of Huakang Biomedical Holdings Co Ltd.

What unique competitive advantages
does Huakang Biomedical Holdings Co Ltd hold over its rivals?

What risks and challenges
does Huakang Biomedical Holdings Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Huakang Biomedical Holdings Co Ltd.

Provide P/S
for Huakang Biomedical Holdings Co Ltd.

Provide P/E
for Huakang Biomedical Holdings Co Ltd.

Provide P/OCF
for Huakang Biomedical Holdings Co Ltd.

Provide P/FCFE
for Huakang Biomedical Holdings Co Ltd.

Provide P/B
for Huakang Biomedical Holdings Co Ltd.

Provide EV/S
for Huakang Biomedical Holdings Co Ltd.

Provide EV/GP
for Huakang Biomedical Holdings Co Ltd.

Provide EV/EBITDA
for Huakang Biomedical Holdings Co Ltd.

Provide EV/EBIT
for Huakang Biomedical Holdings Co Ltd.

Provide EV/OCF
for Huakang Biomedical Holdings Co Ltd.

Provide EV/FCFF
for Huakang Biomedical Holdings Co Ltd.

Provide EV/IC
for Huakang Biomedical Holdings Co Ltd.

Compare the intrinsic valuations
of Huakang Biomedical Holdings Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Huakang Biomedical Holdings Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Huakang Biomedical Holdings Co Ltd compared to its peers.

Compare the P/E ratios
of Huakang Biomedical Holdings Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Huakang Biomedical Holdings Co Ltd with its peers.

Analyze the financial leverage
of Huakang Biomedical Holdings Co Ltd compared to its main competitors.

Show all profitability ratios
for Huakang Biomedical Holdings Co Ltd.

Provide ROE
for Huakang Biomedical Holdings Co Ltd.

Provide ROA
for Huakang Biomedical Holdings Co Ltd.

Provide ROIC
for Huakang Biomedical Holdings Co Ltd.

Provide ROCE
for Huakang Biomedical Holdings Co Ltd.

Provide Gross Margin
for Huakang Biomedical Holdings Co Ltd.

Provide Operating Margin
for Huakang Biomedical Holdings Co Ltd.

Provide Net Margin
for Huakang Biomedical Holdings Co Ltd.

Provide FCF Margin
for Huakang Biomedical Holdings Co Ltd.

Show all solvency ratios
for Huakang Biomedical Holdings Co Ltd.

Provide D/E Ratio
for Huakang Biomedical Holdings Co Ltd.

Provide D/A Ratio
for Huakang Biomedical Holdings Co Ltd.

Provide Interest Coverage Ratio
for Huakang Biomedical Holdings Co Ltd.

Provide Altman Z-Score Ratio
for Huakang Biomedical Holdings Co Ltd.

Provide Quick Ratio
for Huakang Biomedical Holdings Co Ltd.

Provide Current Ratio
for Huakang Biomedical Holdings Co Ltd.

Provide Cash Ratio
for Huakang Biomedical Holdings Co Ltd.

What is the historical Revenue growth
over the last 5 years for Huakang Biomedical Holdings Co Ltd?

What is the historical Net Income growth
over the last 5 years for Huakang Biomedical Holdings Co Ltd?

What is the current Free Cash Flow
of Huakang Biomedical Holdings Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Huakang Biomedical Holdings Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Huakang Biomedical Holdings Co Ltd

Current Assets 56.3m
Cash & Short-Term Investments 36.7m
Receivables 16.7m
Other Current Assets 3m
Non-Current Assets 10.4m
PP&E 8.6m
Intangibles 1.8m
Current Liabilities 9.7m
Accounts Payable 901k
Other Current Liabilities 8.8m
Non-Current Liabilities 611k
Long-Term Debt 596k
Other Non-Current Liabilities 15k
Efficiency

Earnings Waterfall
Huakang Biomedical Holdings Co Ltd

Revenue
25.1m CNY
Cost of Revenue
-8.7m CNY
Gross Profit
16.4m CNY
Operating Expenses
-22.9m CNY
Operating Income
-6.5m CNY
Other Expenses
416k CNY
Net Income
-6.1m CNY

Free Cash Flow Analysis
Huakang Biomedical Holdings Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Huakang Biomedical Holdings Co Ltd's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

31/100
Profitability
Score

Huakang Biomedical Holdings Co Ltd's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Huakang Biomedical Holdings Co Ltd's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
79/100
Solvency
Score

Huakang Biomedical Holdings Co Ltd's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Huakang Biomedical Holdings Co Ltd

There are no price targets for Huakang Biomedical Holdings Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Huakang Biomedical Holdings Co Ltd?

Click here to dive deeper.

Dividends

Huakang Biomedical Holdings Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Huakang Biomedical Holdings Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Huakang Biomedical Holdings Co Ltd

Country

Hong Kong

Industry

Health Care

Market Cap

92.6m HKD

Dividend Yield

0%

Description

Huakang Biomedical Holdings Co. Ltd. operates as a medical group company. The company employs 83 full-time employees The company went IPO on 2018-12-13. The IVD reagents include male fertility IVD reagents, Epstein-Barr virus antibody detection reagents ad parasite antibody detection reagents, among others. The male fertility IVD reagents include sperm function test products, accessory genital glands test products, anti-sperm antibody test products, as well as male reproductive tract infection test products, among others. In addition, the Company is also involved in the sale of auxiliary reproductive supplies and equipments, such as glass coverslips and sperm sample collection cups.

Contact

3/F, Effectual Building, 16 Hennessy Road, Wanchai
+85222028989.0
www.huakangbiomedical.com

IPO

2018-12-13

Employees

83

Officers

Chairman of the Board
Mr. Shuguang Zhang
CEO & Executive Director
Mr. Chunguang Zhang
CFO, Compliance Officer & Executive Director
Mr. Lai Yin Poon CPA (Aust.), CPA (HKICPA)
Business Development Director & Executive Director
Mr. Jiaming He
Financial Controller & Company Secretary
Mr. Lai Ki Chau

See Also

Discover More
What is the Intrinsic Value of one Huakang Biomedical Holdings Co Ltd stock?

The intrinsic value of one Huakang Biomedical Holdings Co Ltd stock under the Base Case scenario is 0.089 HKD.

Is Huakang Biomedical Holdings Co Ltd stock undervalued or overvalued?

Compared to the current market price of 0.185 HKD, Huakang Biomedical Holdings Co Ltd is Overvalued by 52%.

Back to Top